BlueCrest Capital Management Ltd - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlueCrest Capital Management Ltd ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q3 2021$662,000
-3.6%
1,000,0000.0%0.02%
+38.5%
Q2 2021$687,000
-0.3%
1,000,0000.0%0.01%
+18.2%
Q1 2021$689,000
+20.7%
1,000,0000.0%0.01%
-15.4%
Q4 2020$571,000
-11.3%
1,000,0000.0%0.01%
-45.8%
Q3 2020$644,000
-9.3%
1,000,0000.0%0.02%
-36.8%
Q2 2020$710,000
-13.4%
1,000,000
-33.3%
0.04%
-33.3%
Q1 2020$820,000
-29.4%
1,500,0000.0%0.06%
-24.0%
Q4 2019$1,162,000
-7.6%
1,500,0000.0%0.08%
-13.8%
Q3 2019$1,257,000
-6.3%
1,500,0000.0%0.09%
-8.4%
Q2 2019$1,342,0001,500,0000.10%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Cowen Prime Advisors LLC 7,580,000$5,330,0001.98%
Samjo Capital LLC 2,600,000$1,828,0001.34%
PenderFund Capital Management Ltd. 5,560,000$5,031,0001.32%
Indaba Capital Management, L.P. 11,000,000$7,698,0000.82%
Saltoro Capital, LP 900,000$642,0000.23%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 8,000,000$5,625,0000.08%
WOLVERINE ASSET MANAGEMENT LLC 4,000,000$2,814,0000.02%
INGALLS & SNYDER LLC 815,000$532,0000.02%
BlueCrest Capital Management Ltd 1,000,000$662,0000.02%
Citadel Advisors 65,655,000$46,617,0000.01%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders